| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 118 |
| 1 | ETANERCEPT | 103 |
| 2 | UPADACITINIB | 75 |
| 3 | GABAPENTIN | 70 |
| 4 | INTERFERON BETA-1A | 61 |
| 5 | RISANKIZUMAB-RZAA | 61 |
| 6 | PREGABALIN | 60 |
| 7 | METHOTREXATE SODIUM | 58 |
| 8 | ALENDRONATE SODIUM | 56 |
| 9 | METHOTREXATE | 54 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 155 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 131 |
| 2 | Corticosteroid [EPC] | 84 |
| 3 | Benzodiazepine [EPC] | 77 |
| 4 | Janus Kinase Inhibitor [EPC] | 77 |
| 5 | Interleukin-23 Antagonist [EPC] | 71 |
| 6 | Interferon beta [EPC] | 62 |
| 7 | Vitamin C [EPC] | 55 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 52 |
| 9 | HMG-CoA Reductase Inhibitor [EPC] | 49 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 13 | 0.0189 |
| 1 | Melanocortin 4 Receptor Agonist [EPC] | 1 | 0.0035 |
| 2 | Provitamin D2 Compound [EPC] | 46 | 0.0015 |
| 3 | Endoglycosidase [EPC] | 2 | 0.0011 |
| 4 | Methylating Agent [EPC] | 1 | 0.0010 |
| 5 | Neonatal Fc Receptor Blocker [EPC] | 4 | 0.0009 |
| 6 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 6 | 0.0009 |
| 7 | Interleukin-23 Antagonist [EPC] | 71 | 0.0007 |
| 8 | Muscle Relaxant [EPC] | 24 | 0.0005 |
| 9 | Dopamine and Norepinephrine Reuptake Inhibitor [EPC] | 2 | 0.0005 |